Dracofoam infection is a foam wound pad for infected wounds and an ideal means of fighter -free fighter -free fighter of chronic and acute wounds.

Microorganisms are inactivated in the polyurethane foam by antimicrobially effective polyhexanide (PHMB). The polyhexanide contained in the wound base acts as a barrier, absorbs microorganisms from the woundx studio and counteracts colonization and spread of bacteria within the edition. The germ load is reduced, wound infections can be prevented or the spread can be contained.

Due to a powerful exudate recording and abdominal steam rate as well as granulation promotion through the opposite arch to the wound floor, Dracofoam contributes to combating wound infection and faster wound healing. It is pleasant in the application for the patient, since polyhexanide has no absorption or development development. Particularly good tissue compatibility ensures suitability even with non -intact wound environmental skin. The foam wound edition does not glue with the wound and thus minimizes pain when changing the association.

The wound base enables good gas exchange and creates an ideal -moist wound climate. Therefore, Dracofoam infection is also well suited for wound care for chronic and secondary healing wounds. Dracofoam infection can be used for the supply of strongly exuding wounds, in acute and chronic, moderately to strongly exuding wounds in the exudation and granulation phase, as well as with superficial wounds, ulcus cruris, pressure ulcer, diabetic foot, 2nd degree and on skin donation areas.

Dracofoam infection can be used under compression therapy. Dracofoam infection is not self -adhering and can be optimally fixed with the elastic fixing bandages Dracosumbi or Dracoelfi, for example.

Trot time: up to 7 days

Material:
•hydrophilic, absorbing polyurethane foam, polyhexanide